Literature DB >> 30044985

Insights into the Mutational Burden of Human Induced Pluripotent Stem Cells from an Integrative Multi-Omics Approach.

Matteo D'Antonio1, Paola Benaglio1, David Jakubosky2, William W Greenwald3, Hiroko Matsui1, Margaret K R Donovan4, He Li1, Erin N Smith5, Agnieszka D'Antonio-Chronowska1, Kelly A Frazer6.   

Abstract

To understand the mutational burden of human induced pluripotent stem cells (iPSCs), we sequenced genomes of 18 fibroblast-derived iPSC lines and identified different classes of somatic mutations based on structure, origin, and frequency. Copy-number alterations affected 295 kb in each sample and strongly impacted gene expression. UV-damage mutations were present in ∼45% of the iPSCs and accounted for most of the observed heterogeneity in mutation rates across lines. Subclonal mutations (not present in all iPSCs within a line) composed 10% of point mutations and, compared with clonal variants, showed an enrichment in active promoters and increased association with altered gene expression. Our study shows that, by combining WGS, transcriptome, and epigenome data, we can understand the mutational burden of each iPSC line on an individual basis and suggests that this information could be used to prioritize iPSC lines for models of specific human diseases and/or transplantation therapy.
Copyright © 2018 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  RNA-seq; UV damage; epigenome; iPSCs; somatic mutations; stem cells; sublonal mutations; whole genome sequencing

Mesh:

Year:  2018        PMID: 30044985      PMCID: PMC6467479          DOI: 10.1016/j.celrep.2018.06.091

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  53 in total

1.  Expression and activity of L-Myc in normal mouse development.

Authors:  K S Hatton; K Mahon; L Chin; F C Chiu; H W Lee; D Peng; S D Morgenbesser; J Horner; R A DePinho
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

2.  Whole-genome sequencing identifies a recurrent functional synonymous mutation in melanoma.

Authors:  Jared J Gartner; Stephen C J Parker; Todd D Prickett; Ken Dutton-Regester; Michael L Stitzel; Jimmy C Lin; Sean Davis; Vijaya L Simhadri; Sujata Jha; Nobuko Katagiri; Valer Gotea; Jamie K Teer; Xiaomu Wei; Mario A Morken; Umesh K Bhanot; Guo Chen; Laura L Elnitski; Michael A Davies; Jeffrey E Gershenwald; Hannah Carter; Rachel Karchin; William Robinson; Steven Robinson; Steven A Rosenberg; Francis S Collins; Giovanni Parmigiani; Anton A Komar; Chava Kimchi-Sarfaty; Nicholas K Hayward; Elliott H Margulies; Yardena Samuels
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-30       Impact factor: 11.205

3.  Karotypic abnormalities in human induced pluripotent stem cells and embryonic stem cells.

Authors:  Seth M Taapken; Benjamin S Nisler; Michael A Newton; Tori L Sampsell-Barron; Kimberly A Leonhard; Erik M McIntire; Karen D Montgomery
Journal:  Nat Biotechnol       Date:  2011-04       Impact factor: 54.908

4.  Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture.

Authors:  Louise C Laurent; Igor Ulitsky; Ileana Slavin; Ha Tran; Andrew Schork; Robert Morey; Candace Lynch; Julie V Harness; Sunray Lee; Maria J Barrero; Sherman Ku; Marina Martynova; Ruslan Semechkin; Vasiliy Galat; Joel Gottesfeld; Juan Carlos Izpisua Belmonte; Chuck Murry; Hans S Keirstead; Hyun-Sook Park; Uli Schmidt; Andrew L Laslett; Franz-Josef Muller; Caroline M Nievergelt; Ron Shamir; Jeanne F Loring
Journal:  Cell Stem Cell       Date:  2011-01-07       Impact factor: 24.633

5.  Promotion of direct reprogramming by transformation-deficient Myc.

Authors:  Masato Nakagawa; Nanako Takizawa; Megumi Narita; Tomoko Ichisaka; Shinya Yamanaka
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-26       Impact factor: 11.205

Review 6.  Cancer driver mutations in protein kinase genes.

Authors:  Ali Torkamani; Gennady Verkhivker; Nicholas J Schork
Journal:  Cancer Lett       Date:  2008-12-10       Impact factor: 8.679

7.  COSMIC: exploring the world's knowledge of somatic mutations in human cancer.

Authors:  Simon A Forbes; David Beare; Prasad Gunasekaran; Kenric Leung; Nidhi Bindal; Harry Boutselakis; Minjie Ding; Sally Bamford; Charlotte Cole; Sari Ward; Chai Yin Kok; Mingming Jia; Tisham De; Jon W Teague; Michael R Stratton; Ultan McDermott; Peter J Campbell
Journal:  Nucleic Acids Res       Date:  2014-10-29       Impact factor: 16.971

8.  Deciphering signatures of mutational processes operative in human cancer.

Authors:  Ludmil B Alexandrov; Serena Nik-Zainal; David C Wedge; Peter J Campbell; Michael R Stratton
Journal:  Cell Rep       Date:  2013-01-10       Impact factor: 9.423

9.  Signatures of mutational processes in human cancer.

Authors:  Ludmil B Alexandrov; Serena Nik-Zainal; David C Wedge; Samuel A J R Aparicio; Sam Behjati; Andrew V Biankin; Graham R Bignell; Niccolò Bolli; Ake Borg; Anne-Lise Børresen-Dale; Sandrine Boyault; Birgit Burkhardt; Adam P Butler; Carlos Caldas; Helen R Davies; Christine Desmedt; Roland Eils; Jórunn Erla Eyfjörd; John A Foekens; Mel Greaves; Fumie Hosoda; Barbara Hutter; Tomislav Ilicic; Sandrine Imbeaud; Marcin Imielinski; Marcin Imielinsk; Natalie Jäger; David T W Jones; David Jones; Stian Knappskog; Marcel Kool; Sunil R Lakhani; Carlos López-Otín; Sancha Martin; Nikhil C Munshi; Hiromi Nakamura; Paul A Northcott; Marina Pajic; Elli Papaemmanuil; Angelo Paradiso; John V Pearson; Xose S Puente; Keiran Raine; Manasa Ramakrishna; Andrea L Richardson; Julia Richter; Philip Rosenstiel; Matthias Schlesner; Ton N Schumacher; Paul N Span; Jon W Teague; Yasushi Totoki; Andrew N J Tutt; Rafael Valdés-Mas; Marit M van Buuren; Laura van 't Veer; Anne Vincent-Salomon; Nicola Waddell; Lucy R Yates; Jessica Zucman-Rossi; P Andrew Futreal; Ultan McDermott; Peter Lichter; Matthew Meyerson; Sean M Grimmond; Reiner Siebert; Elías Campo; Tatsuhiro Shibata; Stefan M Pfister; Peter J Campbell; Michael R Stratton
Journal:  Nature       Date:  2013-08-14       Impact factor: 49.962

10.  Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples.

Authors:  Kristian Cibulskis; Michael S Lawrence; Scott L Carter; Andrey Sivachenko; David Jaffe; Carrie Sougnez; Stacey Gabriel; Matthew Meyerson; Eric S Lander; Gad Getz
Journal:  Nat Biotechnol       Date:  2013-02-10       Impact factor: 54.908

View more
  29 in total

1.  Discovery and quality analysis of a comprehensive set of structural variants and short tandem repeats.

Authors:  David Jakubosky; Erin N Smith; Matteo D'Antonio; Marc Jan Bonder; William W Young Greenwald; Agnieszka D'Antonio-Chronowska; Hiroko Matsui; Oliver Stegle; Stephen B Montgomery; Christopher DeBoever; Kelly A Frazer
Journal:  Nat Commun       Date:  2020-06-10       Impact factor: 14.919

2.  Metabolic engineering generates a transgene-free safety switch for cell therapy.

Authors:  Volker Wiebking; James O Patterson; Renata Martin; Monica K Chanda; Ciaran M Lee; Waracharee Srifa; Gang Bao; Matthew H Porteus
Journal:  Nat Biotechnol       Date:  2020-07-13       Impact factor: 54.908

3.  In heart failure reactivation of RNA-binding proteins is associated with the expression of 1,523 fetal-specific isoforms.

Authors:  Matteo D'Antonio; Jennifer P Nguyen; Timothy D Arthur; Hiroko Matsui; Margaret K R Donovan; Agnieszka D'Antonio-Chronowska; Kelly A Frazer
Journal:  PLoS Comput Biol       Date:  2022-02-28       Impact factor: 4.475

4.  Hierarchical confounder discovery in the experiment-machine learning cycle.

Authors:  Alex Rogozhnikov; Pavan Ramkumar; Rishi Bedi; Saul Kato; G Sean Escola
Journal:  Patterns (N Y)       Date:  2022-02-22

Review 5.  Context-aware synthetic biology by controller design: Engineering the mammalian cell.

Authors:  Nika Shakiba; Ross D Jones; Ron Weiss; Domitilla Del Vecchio
Journal:  Cell Syst       Date:  2021-06-16       Impact factor: 11.091

6.  Reprogramming enriches for somatic cell clones with small-scale mutations in cancer-associated genes.

Authors:  Maike Kosanke; Katarzyna Osetek; Alexandra Haase; Lutz Wiehlmann; Colin Davenport; Adrian Schwarzer; Felix Adams; Marc-Jens Kleppa; Axel Schambach; Sylvia Merkert; Stephanie Wunderlich; Sandra Menke; Marie Dorda; Ulrich Martin
Journal:  Mol Ther       Date:  2021-04-06       Impact factor: 12.910

7.  Correlation Between Genetic Abnormalities in Induced Pluripotent Stem Cell-Derivatives and Abnormal Tissue Formation in Tumorigenicity Tests.

Authors:  Takako Yamamoto; Yoji Sato; Satoshi Yasuda; Masayuki Shikamura; Takashi Tamura; Chiemi Takenaka; Naoko Takasu; Masaki Nomura; Hiromi Dohi; Masayo Takahashi; Michiko Mandai; Yonehiro Kanemura; Masaya Nakamura; Hideyuki Okano; Shin Kawamata
Journal:  Stem Cells Transl Med       Date:  2022-05-27       Impact factor: 7.655

Review 8.  Human Induced Pluripotent Stem Cells: From Cell Origin, Genomic Stability, and Epigenetic Memory to Translational Medicine.

Authors:  Mareike S Poetsch; Anna Strano; Kaomei Guan
Journal:  Stem Cells       Date:  2022-06-22       Impact factor: 5.845

9.  A circular RNA map for human induced pluripotent stem cells of foetal origin.

Authors:  Mario Barilani; Alessandro Cherubini; Valeria Peli; Francesca Polveraccio; Valentina Bollati; Federica Guffanti; Alessandro Del Gobbo; Cristiana Lavazza; Silvia Giovanelli; Nicola Elvassore; Lorenza Lazzari
Journal:  EBioMedicine       Date:  2020-06-20       Impact factor: 8.143

Review 10.  Mutational signatures: emerging concepts, caveats and clinical applications.

Authors:  Gene Koh; Andrea Degasperi; Xueqing Zou; Sophie Momen; Serena Nik-Zainal
Journal:  Nat Rev Cancer       Date:  2021-07-27       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.